In patients with EGFR mutation, pleural invasion, endobronchial metastasis, and lymph node metastasis rates were 62.5, 39.1, and 34.4%, respectively, indicating statistically significant differences (p = 0.003). The gene discussed is EGFR; the disease is metastatic malignant neoplasm in the lymph nodes.